BETHESDA, Md.--(BUSINESS WIRE)--REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) www.regenerx.com announced that its President and Chief Executive Officer, J.J. Finkelstein, is making a corporate presentation today at the Biotechnology Industry Organization’s (BIO) 2007 Business Forum at 10:30 a.m. in Boston. Mr. Finkelstein will highlight the company’s technology platform, clinical program, and provide a brief overview on RegeneRx’s Phase 2 ophthalmic and Phase 1A cardiovascular clinical trials, recently cleared by the FDA. CEO’s from over 250 biotechnology and pharmaceutical companies from around the world will make business development-focused presentations at the four day meeting. Twenty thousand biotechnology professionals are expected to attend the conference.
